| answer text |
<p>The UK Government recognises that strengthening TB prevention, diagnosis and treatment
contributes to preventing antimicrobial resistance (AMR) and strengthening health
systems.</p><p> </p><p>Drug-resistant TB currently accounts for one-third of all deaths
from AMR. The UK is leading work on development of new antibiotics and treatment combinations
and new ways to rapidly test for drug resistance. DFID’s support to the Global Fund
helps to ensure rapid rollout of new tools. For example, UK funding has helped to
roll out a new multi-drug-resistant TB treatment regimen in 30 countries where the
Global Fund operates.</p><p> </p><p>Strengthening TB prevention, diagnosis and treatment
also contributes to strengthening broader health systems. The UK’s investment in the
Global Fund is building national capability to deliver quality health services and
contributing to Universal Health Coverage and to ensuring that no country and no person
is left behind.</p>
|
 |
